Explore synthetic DNA’s many applications in cancer research
eBook

Weaving the Fabric of Cancer Research with Synthetic DNA

Modern DNA synthesis platforms empower researchers to explore the molecular world, from next-generation sequencing to cell and gene therapy development.

Share

Recent technological and scientific advances have empowered researchers to better understand the nuanced genetic landscape of cancer and create highly personalized cell and gene therapies. Synthetic DNA is one such modern technology that is central to this process of dissolving cancer’s enigma, forming the basis for critical approaches such as next-generation sequencing (NGS), CRISPR editing, and chimeric antigen receptor T cell (CAR T) therapies.

Download this ebook to explore the many ways that scientists use synthetic DNA in modern cancer research and therapeutic development.

Sponsored by

  • Twist Bio 

Top Image Credit:

©iStock, ktsimage

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies